View in EDS HTML Full Text PDF Full Text

Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer.

Saved in:
Bibliographic Details
Title: Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer.
Authors: Tsimberidou, Apostolia-Maria1 (AUTHOR) atsimber@mdanderson.org, Shaw, Jamie V.2 (AUTHOR), Juric, Dejan3 (AUTHOR), Verschraegen, Claire4 (AUTHOR), Weise, Amy M.5 (AUTHOR), Sarantopoulos, John6 (AUTHOR), Lopes, Gilberto7 (AUTHOR), Nemunaitis, John8 (AUTHOR), Mita, Monica9 (AUTHOR), Park, Haeseong10 (AUTHOR), Ellers-Lenz, Barbara11 (AUTHOR), Tian, Hui2 (AUTHOR), Xiong, Wenyuan12 (AUTHOR), Kaleta, Remigiusz2 (AUTHOR), Kurzrock, Razelle13 (AUTHOR)
Source: Journal of Hematology & Oncology. 8/18/2021, Vol. 14 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17568722
DOI:10.1186/s13045-021-01132-z